Mark Pegram, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Novartis
    Topic: 
    Consultant
    Date added: 
    04/07/2022
    Relationship end date: 
    12/31/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Gilead
    Topic: 
    Consultant
    Date added: 
    04/10/2023
    Relationship end date: 
    12/31/2023
  • Attribution: 
    Spouse or Partner
    Type of financial relationship: 
    Employment
    Ineligible company: 
    Rain Oncology
    Topic: 
    Drug Development
    Date added: 
    04/10/2023
    Relationship end date: 
    12/31/2023
Return to Summit on Cancer Health Disparities (SCHD24)